![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
This article has been cited by other articles:
|
|
 |
|
  Y. S. Bynagari, B. Nagy Jr., F. Tuluc, K. Bhavaraju, S. Kim, K. V. Vijayan, and S. P. Kunapuli Mechanism of Activation and Functional Role of Protein Kinase C{eta} in Human Platelets J. Biol. Chem., May 15, 2009; 284(20): 13413 - 13421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gekel and E. Neher Application of an Epac Activator Enhances Neurotransmitter Release at Excitatory Central Synapses J. Neurosci., August 6, 2008; 28(32): 7991 - 8002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, C. Gould, R. Garza, T. Gao, R. Y. Hampton, and A. C. Newton Amplitude Control of Protein Kinase C by RINCK, a Novel E3 Ubiquitin Ligase J. Biol. Chem., November 16, 2007; 282(46): 33776 - 33787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Goel, H. P. S. Makkar, G. Francis, and K. Becker Phorbol Esters: Structure, Biological Activity, and Toxicity in Animals International Journal of Toxicology, July 1, 2007; 26(4): 279 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vallentin and D. Mochly-Rosen RBCK1, a Protein Kinase CbetaI (PKCbetaI)-interacting Protein, Regulates PKCbeta-dependent Function J. Biol. Chem., January 19, 2007; 282(3): 1650 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Roberts, M. R. Smith, E. J. Feldman, L. Cragg, M. M. Millenson, G. J. Roboz, C. Honeycutt, R. Thune, K. Padavic-Shaller, W. H. Carter, et al. Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma. Clin. Cancer Res., October 1, 2006; 12(19): 5809 - 5816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Faghiri and N. G. Bazan Selective Relocalization and Proteasomal Downregulation of PKC{alpha} Induced by Platelet-Activating Factor in Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 397 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Peiretti, M. Canault, D. Bernot, B. Bonardo, P. Deprez-Beauclair, I. Juhan-Vague, and G. Nalbone Proteasome inhibition activates the transport and the ectodomain shedding of TNF-{alpha} receptors in human endothelial cells J. Cell Sci., March 1, 2005; 118(5): 1061 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kedei, D. J. Lundberg, A. Toth, P. Welburn, S. H. Garfield, and P. M. Blumberg Characterization of the Interaction of Ingenol 3-Angelate with Protein Kinase C Cancer Res., May 1, 2004; 64(9): 3243 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Clark, A. R. Black, O. V. Leontieva, M. R. Frey, M. A. Pysz, L. Kunneva, A. Woloszynska-Read, D. Roy, and J. D. Black Involvement of the ERK Signaling Cascade in Protein Kinase C-mediated Cell Cycle Arrest in Intestinal Epithelial Cells J. Biol. Chem., March 5, 2004; 279(10): 9233 - 9247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. V. Leontieva and J. D. Black Identification of Two Distinct Pathways of Protein Kinase C{alpha} Down-regulation in Intestinal Epithelial Cells J. Biol. Chem., February 13, 2004; 279(7): 5788 - 5801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dowlati, H. M. Lazarus, P. Hartman, J. W. Jacobberger, C. Whitacre, S. L. Gerson, P. Ksenich, B. W. Cooper, P. S. Frisa, M. Gottlieb, et al. Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies Clin. Cancer Res., December 1, 2003; 9(16): 5929 - 5935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, Z. Wang, P. Dent, and S. Grant Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells Blood, May 1, 2003; 101(9): 3648 - 3657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gardner and M. E. Olah Distinct Protein Kinase C Isoforms Mediate Regulation of Vascular Endothelial Growth Factor Expression by A2A Adenosine Receptor Activation and Phorbol Esters in Pheochromocytoma PC12 Cells J. Biol. Chem., April 18, 2003; 278(17): 15421 - 15428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cartee, S. C. Maggio, R. Smith, H. M. Sankala, P. Dent, and S. Grant Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol Mol. Cancer Ther., January 1, 2003; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, Z. Wang, and S. Grant Bryostatin 1 and UCN-01 Potentiate 1-beta -D-Arabinofuranosylcytosine-Induced Apoptosis in Human Myeloid Leukemia Cells through Disparate Mechanisms Mol. Pharmacol., January 1, 2003; 63(1): 232 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Junoy, H. Maccario, J.-L. Mas, A. Enjalbert, and S. V. Drouva Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC ({alpha}, {epsilon}, {zeta}) in {alpha}T3-1 and L{beta}T2 Gonadotrope Cell Lines Endocrinology, April 1, 2002; 143(4): 1386 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Benimetskaya, P. Miller, S. Benimetsky, A. Maciaszek, P. Guga, S. L. Beaucage, A. Wilk, A. Grajkowski, A. L. Halperin, and C. A. Stein Inhibition of Potentially Anti-Apoptotic Proteins by Antisense Protein Kinase C-alpha (Isis 3521) and Antisense bcl-2 (G3139) Phosphorothioate Oligodeoxynucleotides: Relationship to the Decreased Viability of T24 Bladder and PC3 Prostate Cancer Cells Mol. Pharmacol., December 1, 2001; 60(6): 1296 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dent and S. Grant Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783. [Full Text]
|
|
|
|
|
|
J. A. Vrana and S. Grant Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade Blood, April 1, 2001; 97(7): 2105 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Prevostel, V Alice, D Joubert, and P. Parker Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment J. Cell Sci., January 7, 2000; 113(14): 2575 - 2584. [Abstract] [PDF]
|
|
|
|
|
|
P. S. Lorenzo, K. Bogi, K. M. Hughes, M. Beheshti, D. Bhattacharyya, S. H. Garfield, G. R. Pettit, and P. M. Blumberg Differential Roles of the Tandem C1 Domains of Protein Kinase C {{delta}} in the Biphasic Down-Regulation Induced by Bryostatin 1 Cancer Res., December 1, 1999; 59(24): 6137 - 6144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Johnson, A. Hageboutros, K. Wang, L. High, J. B. Smith, and R. B. Diasio Life-Threatening Toxicity in a Dihydropyrimidine Dehydrogenase-deficient Patient after Treatment with Topical 5-Fluorouracil Clin. Cancer Res., August 1, 1999; 5(8): 2006 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Strassheim, L. G. May, K. A. Varker, H. L. Puhl, S. H. Phelps, R. A. Porter, R. S. Aronstam, J. D. Noti, and C. L. Williams M3 Muscarinic Acetylcholine Receptors Regulate Cytoplasmic Myosin by a Process Involving RhoA and Requiring Conventional Protein Kinase C Isoforms J. Biol. Chem., June 25, 1999; 274(26): 18675 - 18685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tang and S. H. Leppla Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages Infect. Immun., June 1, 1999; 67(6): 3055 - 3060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Penela, A. Ruiz-Gomez, J. G. Castano, and F. Mayor Jr. Degradation of the G Protein-coupled Receptor Kinase 2 by the Proteasome Pathway J. Biol. Chem., December 25, 1998; 273(52): 35238 - 35244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Prekeris, R. M. Hernandez, M. W. Mayhew, M. K. White, and D. M. Terrian Molecular Analysis of the Interactions between Protein Kinase C-epsilon and Filamentous Actin J. Biol. Chem., October 9, 1998; 273(41): 26790 - 26798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Favit, M. Grimaldi, T. J. Nelson, and D. L. Alkon Alzheimer's-specific effects of soluble beta -amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts PNAS, May 12, 1998; 95(10): 5562 - 5567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Lorenzo, K. Bogi, P. Acs, G. R. Pettit, and P. M. Blumberg The Catalytic Domain of Protein Kinase Cdelta Confers Protection from Down-regulation Induced by Bryostatin 1 J. Biol. Chem., December 26, 1997; 272(52): 33338 - 33343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, L. Smith, M. R. Johnson, K. Wang, R. B. Diasio, and J. B. Smith Activation of Protein Kinase C Induces Nuclear Translocation of RFX1 and Down-regulates c-myc via an Intron 1 X Box in Undifferentiated Leukemia HL-60 Cells J. Biol. Chem., October 6, 2000; 275(41): 32227 - 32233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Smith, L. Chen, M. E. Reyland, T. A. DeVries, R. V. Talanian, S. Omura, and J. B. Smith Activation of Atypical Protein Kinase C zeta by Caspase Processing and Degradation by the Ubiquitin-Proteasome System J. Biol. Chem., December 15, 2000; 275(51): 40620 - 40627. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
